Daniel E. Meyers
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 23
- Cancer Immunotherapy and Biomarkers 17
- CAR-T cell therapy research 5
- Colorectal Cancer Treatments and Studies 4
- Lung Cancer Research Studies 3
-
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Don Morris (15 shared papers)Shantanu Banerji (4 shared papers)Igor Stukalin (18 shared papers)Aliyah Pabani (12 shared papers)Tina Cheng (8 shared papers)Kristina Jenei (4 shared papers)Chandini M. Thirukkumaran (3 shared papers)Bishal Gyawali (6 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)JAMA Network Open (4 papers)Journal of Cancer Policy (2 papers)Frontiers in Oncology (2 papers)Cancer Medicine (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Daniel E. Meyers
39 papers receiving 652 citations
Daniel E. Meyers's Hit Papers
Peers
Comparison fields: 5 of 66
- Oncology 347
- Immunology 74
- Pulmonary and Respiratory Medicine 103
- Hepatology 25
- Hematology 30
Countries citing papers authored by Daniel E. Meyers
This map shows the geographic impact of Daniel E. Meyers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Meyers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Meyers more than expected).
Fields of papers citing papers by Daniel E. Meyers
This network shows the impact of papers produced by Daniel E. Meyers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Meyers. The network helps show where Daniel E. Meyers may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel E. Meyers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors Hit paper breakdown → | 2024 | 71 |
| 2 | 2018 | 59 | |
| 3 | 2019 | 57 | |
| 4 | 2022 | 47 | |
| 5 | 2018 | 44 | |
| 6 | 2021 | 33 | |
| 7 | 2021 | 29 | |
| 8 | 2018 | 26 | |
| 9 | 2021 | 23 | |
| 10 | 2017 | 21 | |
| 11 | 2017 | 20 | |
| 12 | 2021 | 20 | |
| 13 | 2013 | 20 | |
| 14 | 2020 | 19 | |
| 15 | 2020 | 18 | |
| 16 | 2023 | 16 | |
| 17 | 2022 | 15 | |
| 18 | 2020 | 15 | |
| 19 | 2021 | 15 | |
| 20 | 2023 | 11 |
About Daniel E. Meyers
Daniel E. Meyers is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Economics and Econometrics, Genetics and Hepatology, having authored 41 papers that have together received 656 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Lung Cancer Treatments and Mutations (8 papers), CAR-T cell therapy research (5 papers), Economic and Financial Impacts of Cancer (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Research Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Oncology (347 citations), Immunology (74 citations), Pulmonary and Respiratory Medicine (103 citations), Hepatology (25 citations) and Hematology (30 citations). Daniel E. Meyers has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Don Morris, Shantanu Banerji, Igor Stukalin, Aliyah Pabani, Tina Cheng, Kristina Jenei, Chandini M. Thirukkumaran, Bishal Gyawali, Daniel Yick Chin Heng and Michelle L. Dean. Their work appears in journals such as Journal of Clinical Oncology, JAMA Network Open, Journal of Cancer Policy, Frontiers in Oncology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.